Premium
Anaemia management protocols in the care of haemodialysis patients: examining patient outcomes
Author(s) -
Saunders Sushila,
MacLeod Martha LP,
Salyers Vince,
MacMillan Peter D,
Ogborn Malcolm R
Publication year - 2013
Publication title -
journal of clinical nursing
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.94
H-Index - 102
eISSN - 1365-2702
pISSN - 0962-1067
DOI - 10.1111/jocn.12059
Subject(s) - medicine , erythropoietin , transferrin saturation , protocol (science) , retrospective cohort study , intravenous iron , intensive care medicine , iron deficiency , emergency medicine , anemia , alternative medicine , pathology
Aims and objectives To determine whether the use of a nurse‐driven protocol in the haemodialysis setting is as safe and effective as traditional physician‐driven approaches to anaemia management. Background The role of haemodialysis nurses in renal anaemia management has evolved through the implementation of nurse‐driven protocols, addressing the trend of exceeding haemoglobin targets and rising costs of erythropoietin‐stimulating agents. Design Retrospective, non‐equivalent case control group design. Methods The sample was from three haemodialysis units in a control group ( n = 64) and three haemodialysis units in a protocol group ( n = 43). The protocol group used a nurse‐driven renal anaemia management protocol, while the control group used a traditional physician‐driven approach to renal anaemia management. All retrospective data were obtained from a provincial renal database. Data were analysed using chi‐square tests and t ‐tests. Patient outcomes examined were haemoglobin levels, transferrin saturation levels, erythropoietin‐stimulating agents use and intravenous iron use. Cost comparisons were determined using average use of erythropoietin‐stimulating agents and intravenous iron. Results Control and protocol groups reached haemoglobin target levels. In the protocol group, 75% reached transferrin saturation target levels in comparison with 25% of the control group. Use and costs for iron was higher in the control group, while use and costs for erythropoietin was higher in the protocol group. The higher usage of erythropoietin‐stimulating agents was potentially related to comorbid conditions amongst the protocol group. Conclusions A nurse‐driven protocol approach to renal anaemia management was as effective as the physician‐driven approach in reaching haemoglobin and transferrin saturation levels. Further examination of the use and dosing of erythropoietin‐stimulating agents and intravenous iron, their impact on haemoglobin levels related to patient comorbidities and subsequent cost effectiveness of protocols is required. Relevance to clinical practice Using a nurse‐driven protocol in practice supports the independent nursing role while contributing to safe patient outcomes.